Premium
Glucose tolerance prior to and during therapy with contraceptive steroids
Author(s) -
Danowski T. S.,
Sabeh G.,
Alley R. A.,
Robbins T. J.,
Tsai C. T.,
Sekaran K.
Publication year - 1968
Publication title -
clinical pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.941
H-Index - 188
eISSN - 1532-6535
pISSN - 0009-9236
DOI - 10.1002/cpt196892223
Subject(s) - norethynodrel , mestranol , medicine , oral administration , pharmacology , population , research methodology , physiology , family planning , environmental health
Oral glucose tolerance remained within the pretherapy range during cyclic administration of norethynodrel and ethinyl estradiol 3‐methyl ether (mestranol) in a single tablet to 17 women for 5 to 48 months. Our data and those in the literature indicate that in evaluations of oral contraceptive agents the pretherapy glltcose tolerance, the particular steroids prescribed, the schedule of dosage, and the dmation of therapy and other variables may be critical in establishing effects on glucose tolerance.